Publications in Scientific Journals:
M. Marko, A. Posekany, S. Szabo, S. Scharer, S. Kiechl, M. Knoflach, W. Serles, J. Ferrari, W. Lang, P. Sommer, S. Greisenegger et al.:
"Trends of r-tPA (Recombinant Tissue-Type Plasminogen Activator) Treatment and Treatment-Influencing Factors in Acute Ischemic Stroke";
Stroke,
51
(2020),
4;
8 pages.
English abstract:
Frequencies of treatment with r-tPA (recombinant tissue-type plasminogen activator) are increasing over the past 15 years. However, published data on the influence of various demographic and clinical factors on r-tPA treatment as well as estimates of future trajectories are limited. We evaluated time trends and future trajectories of r-tPA treatment in patients with acute stroke and the influence of various factors on r-tPA treatment by analyzing data of 103 970 patients enrolled in the Austrian Stroke Unit Registry from 2006 to 2018, of which 18 953 were treated with r-tPA.
"Official" electronic version of the publication (accessed through its Digital Object Identifier - DOI)
http://dx.doi.org/10.1161/STROKEAHA.119.027921
Electronic version of the publication:
https://www.ahajournals.org/doi/full/10.1161/STROKEAHA.119.027921
Created from the Publication Database of the Vienna University of Technology.